Dr. James M. Cleary
Claim this profileDana Farber Cancer Institute
Studies Pancreatic Cancer
Studies Gastroesophageal Junction Adenocarcinoma
7 reported clinical trials
14 drugs studied
Area of expertise
1Pancreatic Cancer
Stage IV
BRCA1 positive
BRCA2 positive
2Gastroesophageal Junction Adenocarcinoma
Stage IV
Affiliated Hospitals
Clinical Trials James M. Cleary is currently running
Immunotherapy + Chemotherapy
for Pancreatic Cancer
This study is being done to test the safety and effectiveness of combining domvanalimab (AB154), zimberelimab (AB122), and APX005M with pancreatic cancer that has spread to other parts of body. This research study involves immunotherapy. Immunotherapy triggers the body's immune system to fight cancer cells. The names of the study drugs involved in this study are: * Domvanalimab (also known as AB154) * Zimberelimab (also known as AB122) * APX005M
Recruiting2 awards Phase 1 & 216 criteria
FoundationOne Testing
for Rare Cancers
This open label, non-randomized, multi-center, pragmatic study aims to establish whether patients with rare tumors can benefit from matched molecular therapy as dictated by their next-generation sequencing (NGS) results.
Recruiting1 award N/A12 criteria
More about James M. Cleary
Clinical Trial Related2 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments James M. Cleary has experience with
- Niraparib
- FoundationOne CDx
- FoundationOne Liquid CDx
- APX005M
- Domvanalimab (AB154)
- Zimberelimab (AB122)
Breakdown of trials James M. Cleary has run
Pancreatic Cancer
Gastroesophageal Junction Adenocarcinoma
Skin Cancer
Liver Cancer
Unknown Primary Neoplasm
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does James M. Cleary specialize in?
James M. Cleary focuses on Pancreatic Cancer and Gastroesophageal Junction Adenocarcinoma. In particular, much of their work with Pancreatic Cancer has involved Stage IV patients, or patients who are BRCA1 positive.
Is James M. Cleary currently recruiting for clinical trials?
Yes, James M. Cleary is currently recruiting for 2 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that James M. Cleary has studied deeply?
Yes, James M. Cleary has studied treatments such as Niraparib, FoundationOne CDx, FoundationOne Liquid CDx.
What is the best way to schedule an appointment with James M. Cleary?
Apply for one of the trials that James M. Cleary is conducting.
What is the office address of James M. Cleary?
The office of James M. Cleary is located at: Dana Farber Cancer Institute, Boston, Massachusetts 02115 United States. This is the address for their practice at the Dana Farber Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.